Cargando…

EDITORIAL COMMENT: LACK OF EVIDENCE OF HPV ETIOLOGY OF PROSTATE CANCER FOLLOWING RADICAL SURGERY AND HIGHER FREQUENCY OF THE ARG/PRO GENOTYPE IN TURKISH MEN WITH PROSTATE CANCER

Detalles Bibliográficos
Autor principal:	Pontes, Jose
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Urologia 2017
Materias:	Editorial Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5293382/ https://www.ncbi.nlm.nih.gov/pubmed/28124525 http://dx.doi.org/10.1590/S1677-5538.IBJU.2015.0429.1

Ejemplares similares

Lack of evidence of HPV etiology of prostate cancer following radical surgery and higher frequency of the Arg/Pro genotype in turkish men with prostate cancer
por: Aydin, Merve, et al.
Publicado: (2017)

Editorial Comment to Granulomatous prostatitis with high suspicion of prostatic adenocarcinoma on radiological imaging
por: Sekito, Takanori, et al.
Publicado: (2021)

Comment on “Evidence that the ProPerDP method is inadequate for protein persulfidation detection due to lack of specificity”
por: Dóka, Éva, et al.
Publicado: (2021)

Editorial Comment: Translational research in urology: nutricion and prostate
por: Favorito, Luciano A.
Publicado: (2021)

Comment on Rosenzweig et al. Very Low Prostate PET/CT PSMA Uptake May Be Misleading in Staging Radical Prostatectomy Candidates. J. Pers. Med. 2022, 12, 410
por: Veerman, Hans, et al.
Publicado: (2022)

Editorial Comment to Considerations for the use of gonadotropin‐releasing hormone agonists and antagonists in patients with prostate cancer
por: Kawahara, Takashi
Publicado: (2020)

Pro-tumorigenic role of lnc-ZNF30-3 as a sponge counteracting miR-145-5p in prostate cancer
por: Le Hars, Matthieu, et al.
Publicado: (2023)

Editorial Comment: Overall survival prediction in metastatic castration-resistant prostate cancer treated with radium-223
por: dos Reis, Rodolfo Borges, et al.
Publicado: (2020)

Editorial Comment to Prostate squamous cell carcinoma developing 11 years after external radiotherapy for prostate adenocarcinoma
por: Uehara, Sho
Publicado: (2020)

Editorial Comment: (68)Ga-Prostate-specific membrane antigen (PSMA) positron emission tomography (pet) in prostate cancer: a systematic review and meta-analysis
por: Zequi, Stênio de C.
Publicado: (2021)

Prostate cancer grading, time to go back to the future
por: Egevad, Lars, et al.
Publicado: (2020)

Sympathetic nervous signaling dictates prostate cancer progression
por: Sigorski, D., et al.
Publicado: (2022)

Editorial Comment on Ischemic proctitis after low‐dose‐rate brachytherapy using hydrogel spacer for prostate cancer
por: Tanaka, Nobumichi
Publicado: (2022)

Editorial Comment to Castration‐resistant prostate cancer diagnosed during leuprorelin treatment for spinal and bulbar muscular atrophy
por: Pennuto, Maria, et al.
Publicado: (2022)

Editorial Comment to Primary basal cell carcinoma of the prostate with concurrent adenocarcinoma
por: Funahashi, Yasuhito
Publicado: (2020)

Editorial Comment to Microscopic pulmonary tumor embolism from adenocarcinoma of the prostate
por: Iguchi, Taro, et al.
Publicado: (2020)

Editorial Comment to Undifferentiated pleomorphic sarcoma of the prostate in a young man
por: Ochi, Atsuhiko
Publicado: (2020)

Editorial Comment: Acute prostatitis after prostate biopsy under ciprofloxacin prophylaxis with or without ornidazole and pre-biopsy enema: analysis of 3.479 prostate biopsy cases
por: Diniz, Andre Luiz Lima
Publicado: (2020)

Value of MRI to Improve Deep Learning Model That Identifies High-Grade Prostate Cancer. Comment on Gentile et al. Optimized Identification of High-Grade Prostate Cancer by Combining Different PSA Molecular Forms and PSA Density in a Deep Learning Model. Diagnostics 2021, 11, 335
por: Jue, Joshua S., et al.
Publicado: (2021)

Editorial Comment to Case of atypical femoral fractures that mimicked the typical imaging findings of prostate cancer‐induced bone metastasis
por: Rajeev, TP
Publicado: (2019)

Editorial Comment to Nonmetastatic castration‐resistant prostate cancer treated with salvage focal brachytherapy after external beam radiotherapy
por: Hirayama, Yukiyoshi, et al.
Publicado: (2021)

Editorial Comment to Systemic treatment for coexisting mucinous urethral adenocarcinoma and prostate adenocarcinoma
por: Watari, Shogo, et al.
Publicado: (2020)

Epigenetic mechanisms underlying subtype heterogeneity and tumor recurrence in prostate cancer
por: Chakraborty, Goutam, et al.
Publicado: (2023)

Editorial Comment to Tumor lysis syndrome following cabazitaxel administration for metastatic castration‐resistant prostate cancer: A case report
por: Yamamoto, Yoshiyuki
Publicado: (2019)

Editorial Comment from Dr Suzuki to Solitary recurrence of prostate cancer surrounded by seminal vesicle/vas deferens‐like epithelium
por: Suzuki, Motofumi
Publicado: (2020)

Editorial Comment from Dr Sakamoto to Solitary recurrence of prostate cancer surrounded by seminal vesicle/vas deferens‐like epithelium
por: Sakamoto, Shinichi
Publicado: (2020)

Editorial Comment to Utility of whole‐body diffusion‐weighted magnetic resonance imaging in the management of treatment‐related neuroendocrine prostate cancer
por: Yoshida, Soichiro, et al.
Publicado: (2020)

A Case for Offering HPV Self-Sampling to Well-Screened Women. Comment on Lesack et al. Willingness to Self-Collect a Sample for HPV-Based Cervical Cancer Screening in a Well-Screened Cohort: HPV FOCAL Survey Results. Curr. Oncol. 2022, 29, 3860–3869
por: Kraut, Roni, et al.
Publicado: (2022)

Editorial Comment to Tri‐modality therapy with i‐125 brachytherapy, external beam radiation therapy, and short‐term hormone therapy for high‐risk prostate cancer after holmium laser enucleation of the prostate
por: Tomisaki, Ikko
Publicado: (2022)

Breaking down walls in prostate cancer with the MURAL collection of patient-derived xenografts
por: Bevan, Charlotte L.
Publicado: (2021)

How I faced my prostate cancer: a molecular biologist’s perspective
por: Zuradelli, Monica, et al.
Publicado: (2021)

Association between p53 Pro72Arg polymorphism and prostate cancer risk: a meta-analysis
por: Zhang, Lifeng, et al.
Publicado: (2011)

Editorial Comment to Interstitial lung disease induced by apalutamide therapy for castration‐resistant prostate cancer: A report of a rare case
por: Yuasa, Takeshi
Publicado: (2022)

Active surveillance should be considered for select men with Grade Group 2 prostate cancer
por: Pekala, Kelly R., et al.
Publicado: (2023)

Active surveillance should not be routinely considered in ISUP grade group 2 prostate cancer
por: Gandaglia, Giorgio, et al.
Publicado: (2023)

Editorial Comment to Prostate carcinoma with neuroendocrine differentiation successfully treated by early detection with imaging examination
por: Inamoto, Teruo, et al.
Publicado: (2020)

Editorial Comment: Comparison of pain levels in fusion prostate biopsy and standard TRUS-Guided biopsy
por: Diniz, Andre Luiz Lima
Publicado: (2020)

Editorial Comment to Prominent response to platinum‐based chemotherapy in a patient with BRCA2 mutant‐neuroendocrine prostate cancer and MDM2 amplification
por: Matsumoto, Takashi, et al.
Publicado: (2021)

Comment on Gassenmaier et al. Accelerated T2-Weighted TSE Imaging of the Prostate Using Deep Learning Image Reconstruction: A Prospective Comparison with Standard T2-Weighted TSE Imaging. Cancers 2021, 13, 3593
por: Pucciarelli, Francesco, et al.
Publicado: (2023)

Public online reporting from a nationwide population‐based clinical prostate cancer register
por: Stattin, Pär, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_vevnqakl9s4kph5c9vf18veshu